Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study.
Fiche publication
Date publication
janvier 2023
Journal
Biomarker research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUEANT Jean-Louis, Pr THILLY Nathalie, Dr OUSSALAH Abderrahim
Tous les auteurs :
Oussalah A, Callet J, Manteaux AE, Thilly N, Jay N, Guéant JL, Lozniewski A
Lien Pubmed
Résumé
To assess the association between plasma procalcitonin concentration at hospital admission and the risk of 50-day in-hospital mortality among patients with community-acquired bloodstream infections.
Mots clés
50-day in-hospital mortality, Community-acquired bloodstream infections, Procalcitonin, Risk-stratifying biomarker
Référence
Biomark Res. 2023 01 17;11(1):4